The global 3D bioprinting market to grow at a CAGR of 25.06% during the period 2017-2021.
The report, Global 3D Bioprinting Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is collaboration among the end-users for knowledge sharing purposes. The current end-users of 3D bioprinters are mostly limited to research organizations, bioengineering laboratories, and universities. In April 2016, the Italian Regenerative Medicine Infrastructure (IRMI) has initiated the setting up of advanced infrastructure in the European region to ensure sharing of knowledge and 3D bioprinting technologies among different disciplines in the genre of regenerative medicine. The IRMI is organized and facilitated by nine Italian universities, five research organizations, and seven private societies.
According to the report, one of the major drivers for this market is companies providing low-cost 3d bioprinters penetrating the market. 3D bioprinters are complex and much more advanced than traditional 3D printers. These complexities make the 3D bioprinter expensive to procure. However, the prices of the 3D bioprinters are witnessing a steep decline mainly due to the increasing number of new vendors entering the market. These vendors are providing low-cost 3D bioprinters to low-budget research organizations, laboratories, and universities. Ourobotics that is a startup is selling its 3D bioprinter called Revolution, which uses syringe-based extrusion technology, at the retail price of $14,000.
Further, the report states that one of the major factors hindering the growth of this market is inability of researchers to combine vascular supply in printed tissues and organs. Although the 3D bioprinting market has witnessed major breakthroughs over the years, it is far from bioprinting a fully functional organ or tissue for transplant. The researchers are successful in bioprinting parts of an organ or tissue that has cells fully capable of performing their dedicated functions. However, they haven't been able to combine vascular veins in the printed organs, though it can be printed separately.